Back to trial details

Intake questionnaire

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Applying to University of Colorado Cancer Center · Aurora, Colorado

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced Cancer?
3. Are you able to travel to Aurora for study visits?